We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Johnson & Johnson subsidiary DePuy Synthes has acquired CrossRoads Extremity Systems, a Memphis, Tenn.-based company that will strengthen DePuy’s portfolio in elective foot and ankle implants and surgical instruments. Read More
Two Canadian companies, Imagia Cybernetics and Canexia Health, are merging to create a new entity that will focus on genomic testing and analysis for cancer patients. Read More
Cambridge, Mass.-based Foundation Medicine has teamed up with Eli Lilly for the development of tissue- and blood-based assays as companion diagnostics for Lilly’s cancer drug Retevmo and other therapies. Read More
The EU and its member states must take urgent action to increase the number of notified bodies authorized to certify devices under the EU’s In Vitro Diagnostic Medical Devices Regulation (IVDR) that goes into effect May 26. Read More
Revibe Technologies’ said its medical device software product, FokusRx, for the treatment of children with attention deficit hyperactivity disorder (ADHD) improved participants’ symptoms in a feasibility study. Read More